SLC26A3 mutations in congenital chloride diarrhea
Siru Mäkelä1, Juha Kere, Christer Holmberg
1Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Insights
Congenital chloride diarrhea (CLD) is a genetic disorder affecting intestinal electrolyte absorption. This study reviews SLC26A3 gene mutations, their functional impacts, and clinical relevance in CLD patients.
Area of Science:
- Genetics
- Molecular Biology
- Gastroenterology
Background:
- Congenital chloride diarrhea (CLD) is an autosomal recessive intestinal electrolyte absorption disorder.
- It presents with severe secretory diarrhea, dehydration, and electrolyte imbalances shortly after birth.
- CLD is caused by mutations in the solute carrier family 26, member 3 (SLC26A3) gene.
Purpose of the Study:
- To summarize published and novel SLC26A3 mutations and polymorphisms.
- To review the functional consequences of these genetic variations.
- To analyze their clinical implications in congenital chloride diarrhea.
Main Methods:
- Compilation and review of published SLC26A3 mutations and polymorphisms.
- Inclusion of two newly identified SLC26A3 mutations.
- Analysis of functional consequences and clinical correlations.
Main Results:
- A wide spectrum of SLC26A3 mutations are associated with CLD.
- No clear phenotype-genotype correlation was observed.
- Clinical course variability may be influenced by environmental factors and compensatory mechanisms.
Conclusions:
- SLC26A3 gene mutations are the cause of congenital chloride diarrhea.
- Functional and clinical implications of diverse mutations require further investigation.
- Environmental factors may play a significant role in CLD clinical presentation.
Abstract:
Congenital chloride diarrhea (CLD) is an autosomal recessive disorder of intestinal electrolyte absorption. It is characterized by persistent secretory diarrhea resulting in polyhydramnios and prematurity prenatally, and dehydration, hypoelectrolytemia, hyperbilirubinemia, abdominal distention, and failure to thrive immediately after birth. CLD is caused by mutations in the solute carrier family 26, member 3 gene (SLC26A3, alias CLD or DRA), which encodes a Na+-independent Cl-/HCO3- (or OH-) exchanger. SLC26A3 is a member of the SLC26 sulfate permease/anion transporter family and it is expressed mainly in the apical brush border of intestinal epithelium. The only extraintestinal tissues showing SLC26A3 expression are eccrine sweat glands and seminal vesicles. A wide variety of different mutations in the SLC26A3 gene have been associated with CLD with no apparent evidence of phenotype-genotype correlation. The clinical course of CLD, however, is variable and may rather depend on environmental factors and compensatory mechanisms than mutations. In this report, we present a summary of all published and two novel SLC26A3 mutations and polymorphisms, and review them in the context of their functional consequences and clinical implications.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Mutations
Translation
Translation
Sex-linked Disorders
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...


